State Board of Administration of Florida Retirement System Invests $180,000 in Sotera Health (NASDAQ:SHC)

State Board of Administration of Florida Retirement System acquired a new position in shares of Sotera Health (NASDAQ:SHC – Get Rating) in the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 21,627 shares of the company’s stock, valued at approximately $180,000.

Other large investors have also modified their holdings of the company. Boston Partners lifted its holdings in shares of Sotera Health by 243.2% in the third quarter. Boston Partners now owns 3,109,343 shares of the company’s stock valued at $20,997,000 after purchasing an additional 2,203,400 shares in the last quarter. Alpha Paradigm Partners LLC acquired a new stake in Sotera Health during the third quarter valued at $657,000. Aurora Investment Counsel boosted its position in Sotera Health by 4.1% during the third quarter. Aurora Investment Counsel now owns 63,540 shares of the company’s stock valued at $433,000 after purchasing an additional 2,501 shares during the last quarter. Pacer Advisors Inc. acquired a new stake in Sotera Health during the fourth quarter valued at $160,000. Finally, ExodusPoint Capital Management LP acquired a new stake in Sotera Health during the third quarter valued at $2,223,000. 87.21% of the stock is owned by institutional investors.

Sotera Health Trading Down 0.3 %

Sotera Health stock opened at $14.60 on Tuesday. The company has a debt-to-equity ratio of 6.32, a quick ratio of 1.46 and a current ratio of 1.54. The business’s 50-day simple moving average is $16.54 and its 200-day simple moving average is $13.95. The firm has a market capitalization of $4.12 billion, a PE ratio of -15.70 and a beta of 2.08. Sotera Health has a 52 week low of $5.78 and a 52 week high of $24.90.

Sotera Health (NASDAQ:SHC – Get Rating) last posted its quarterly earnings data on Tuesday, February 28th. The company reported $0.23 EPS for the quarter, topping analysts’ consensus estimates of $0.21 by $0.02. Sotera Health had a positive return on equity of 46.84% and a negative net margin of 26.47%. The business had revenue of $251.59 million for the quarter, compared to analyst estimates of $247.66 million. Equities research analysts forecast that Sotera Health will post 0.75 earnings per share for the current year.

Analysts Set New Price Targets

SHC has been the topic of several recent research reports. JPMorgan Chase & Co. upgraded Sotera Health from an “underweight” rating to a “neutral” rating and raised their target price for the company from $6.00 to $18.00 in a report on Monday, January 23rd. Barclays cut their target price on Sotera Health from $21.00 to $20.00 in a report on Thursday, May 4th. Finally, Royal Bank of Canada raised their target price on Sotera Health from $8.00 to $19.00 and gave the company an “outperform” rating in a report on Wednesday, March 1st. Three investment analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $16.50.

Sotera Health Profile

(Get Rating)

Sotera Health Company provides sterilization, and lab testing and advisory services in the United States, Canada, Europe, and internationally. The company's sterilization services include gamma and electron beam irradiation, and EO processing; Nelson Labs comprise microbiological and analytical chemistry testing; and advisory services for medical device and biopharmaceutical industries.